Developing RxNorm Extension: A Step Toward Global Drug Data Harmonization in Observational Drug Research

Area of Science:

• Pharmacology and Drug Informatics
• Computational Linguistics
• Health Data Standardization

Background:

• International drug data exists in disparate, non-standardized vocabularies.
• Harmonizing drug information is crucial for global drug safety and effectiveness research.
• Existing standards like RxNorm (US) provide a foundation for data normalization.

Purpose of the Study:

• To present RxNorm Extension (RxE), a novel standardized drug vocabulary system.
• To harmonize drug data from multiple international drug repositories.
• To enhance global drug safety and effectiveness research through standardized drug representations.

Main Methods:

• Developed an attribute-based mapping approach for data integration.
• Integrated 12 international drug vocabularies into the RxE system.
• Standardized disparate drug vocabularies to a structure following the US RxNorm reference standard.

Main Results:

• Observed similar dose form and ingredient usage patterns across integrated vocabularies.
• Identified a significantly higher number of worldwide brand names compared to ingredient or dose form variations.
• Highlighted challenges in RxE quality, including brand name discrepancies, poorly structured dosage forms, and faulty dosages.

Conclusions:

• RxNorm Extension (RxE) provides a valuable tool for harmonizing international drug data.
• The attribute-based mapping approach improves consistency and reduces manual data processing.
• Future work should focus on expanding RxE coverage, automating mapping, and fostering international collaboration for optimized global drug safety.